Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
180 participants
INTERVENTIONAL
2012-01-31
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Goal Directed Therapy (PGDT) in Spinal Surgery in the Prone Position
NCT04025086
Fluid ORiented Therapy for yoUNg Asa 1patients
NCT03090399
Goal Directed Therapy for Patients Undergoing Major Vascular Surgery
NCT01681251
Effect of Goal-directed Fluid Therapy on Postoperative Complications
NCT03169998
Perioperative Fluid Therapy in Patients Undergoing Pancreaticoduodenectomy
NCT04687826
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
patients before 2014, in which fluids were administered without FloTrac monitoring
No interventions assigned to this group
case group
patients after 2014, after management of fluid therapy has been guided by FloTrac parameters as a standard clinical practice (NICE protocol)
FloTrac
Stroke Volume has been maintained at 90% of the maximal Stroke Volume as in NICE protocol 2011
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FloTrac
Stroke Volume has been maintained at 90% of the maximal Stroke Volume as in NICE protocol 2011
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Renal Failure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.Andrea Russo
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Valter MD Perilli, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PERILLI-NICE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.